— Know what they know.
Not Investment Advice

PTLF OTC

Petlife Pharmaceuticals, Inc.
1W: +0.0% 1M: +0.0% 3M: -50.0% YTD: +0.0% 1Y: +0.0% 3Y: -95.0% 5Y: -32.2%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 48 · $19675 mcap · 208M float · 0.0001% daily turnover

Balance Sheet Trends

Total Assets
$55K +4593.2% ▲
5Y CAGR: -41.1%
Total Liabilities
$1M -55.6% ▼
5Y CAGR: +1.9%
Shareholders Equity
-$1M +57.3% ▲
Cash & Investments
$54K +4529.2% ▲
5Y CAGR: +40.1%
Total Debt
$717K +368.7% ▲
5Y CAGR: +39.0%
Net Debt
$663K +336.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2013FY2014FY2015FY2016FY2017
— Assets —
Cash$0$7K$0$1K$54K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$0$7K$0$1K$54K
Net Receivables$0$11K$5K$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$0$17K$5K$1K$55K
Property, Plant & Equip.$0$0$0$0$0
Goodwill & Intangibles$0$0$600$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$0$0$600$0$0
Total Assets$0$17K$5K$1K$55K
— Liabilities —
Accounts Payable$214K$0$235K$758K$377K
Short-Term Debt$138K$0$0$153K$717K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities-$673K$0$0$0$102K
Total Current Liabilities$0$0$371K$3M$1M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$0$0
Total Liabilities$0$0$371K$3M$1M
— Equity —
Common Stock$38K$55K$12K$8K$74K
Retained Earnings-$38-$2M-$3M-$7M-$30M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$0$17K-$365K-$3M-$1M
Total Liabilities & Equity$0$17K$5K$1K$55K
— Key Metrics —
Total Debt$138K$0$0$153K$717K
Net Debt$138K-$7K$0$152K$663K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms